Gene 143: 13-20 (1994) ; Langer et al., Biochemistry 36:10867-10871 (1997) ; McKegney et al., Phytochemistry 41:1259 -1263 (1996 ).
Some PAL genes, in addition to their ability to convert phenylalanine to cinnamate, can accept tyrosine as substrate.
In such reactions the enZyme activity is designated tyrosine ammonia lyase Conversion of tyrosine by TAL results in the direct formation of PHCA from tyrosine Without the intermediacy of cinnamate. HoWever, there has been only one, very recent report of a gene Which encodes an enZyme having signi?cantly higher TAL catalytic activity than PAL activity (Kyndt et al., FEBS Letters 512:240-244 (2002) ). This gene Was isolated from the bacterium Rhodo bacter capsulatus and encoded an enZyme that had a TAL catalytic efficiency that Was approximately 150 times higher than that for PAL. This TAL protein Was reported to have a higher homology to the PAL proteins of plants (e.g., 32%
identity With the PAL sequence of Pinus taeda), than to the PAL sequences of yeasts. All other natural PAL/TAL enZymes prefer to use phenylalanine rather than tyrosine as their substrate. The Wild-type PAL/TAL enZyme from the yeast Rhodosporidium exhibits a reduced preference for phenylalanine as compared to tyrosine, having a ratio of TAL catalytic activity to PAL catalytic activity of only 0.58 (reported in Hanson and Havir, In The Biochemistry of Plants; Academic: NeW York, 1981; Vol. 7, pp 577-625) .
For comparison, the PAL/TAL enZymes studied in other organisms typically possess PAL/TAL ratios of 15 or greater. U.S. Pat. No. 6, 368, 837 discloses several methods for the biological production of PHCA. These include: the incor poration of the Wild type PAL from the yeast Rhodotorula glutinis into E. coli and utiliZing the ability of the Wild type PAL to convert tyrosine to PHCA; the incorporation of the Wild type PAL from the yeast Rhodotorula glutinis plus the plant cytochrome P-450 and the P-450 reductase into E. coli to convert phenylalanine to cinnamic acid and then to PHCA; and the development of a mutant PAL/TAL gene that encoded an enZyme With enhanced TAL activity. This mutant gene Was isolated by mutagenesis of the Wild type Rhodosporia'ium toruloia'es PAL and encoded an enZyme With a TAL/PAL ratio of 1.7. This gene Was used to produce PCHA by direct conversion of tyrosine. The development of several other mutant PAL/TAL genes that encode enZymes With enhanced TAL activity is disclosed in US. Pat. No. 6, 521, 748 . TAL/PAL ratios up to 7.2 Were reported from these mutant genes. HoWever, other PAL/TAL enZymes With higher TAL activity are required for the economical produc tion of PCHA. The problem to be solved therefore is to obtain a naturally occurring enZyme With higher TAL than PAL activity to be used for the direct conversion of tyrosine to PHCA and to serve as a tool for future enZyme engineering to produce more ef?cient TAL enZymes. Applicants have solved the stated problem by isolating an enZyme from Trichosporon cutanem that has a higher TAL catalytic activity than PAL activity. Furthermore, the gene for this enZyme is induced by the presence of tyrosine rather than phenylalanine.
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SUMMARY OF THE INVENTION
The invention provides an isolated nucleic acid molecule encoding a tyrosine ammonia lyase enZyme, selected from the group consisting of: a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:25;  b) an isolated nucleic acid molecule that hybridiZes With (a) under the folloWing hybridization conditions: 0.1x SSC, 0.1% SDS, 65° C. and Washed With 2><SSC, 0.1% SDS folloWed by 0.1><SSC, 0.1% SDS; or an isolated nucleic acid molecule that is complementary to (a) or Additionally the invention provides polypeptides encoded by the nucleic acids of the invention as Well as genetic chimera and transformed host cells containing the same.
In another embodiment the invention provides a method of obtaining a nucleic acid molecule encoding a tyrosine ammonia lyase enZyme comprising: a) probing a genomic library With the nucleic acid mol ecule of the invention b) identifying a DNA clone that hybridiZes With the nucleic acid molecule of the invention; and c) sequencing the genomic fragment that comprises the clone identi?ed in step (b), Wherein the sequenced genomic fragment encodes a tyrosine ammonia lyase enZyme.
Similarly the invention provides a method of obtaining a nucleic acid molecule encoding a tyrosine ammonia lyase enZyme comprising: a) synthesizing at least one oligonucleotide primer corre sponding to a portion of the sequence as set forth in SEQ ID NO:24; and b) amplifying an insert present in a cloning vector using the oligonucleotide primer of step (a); Wherein the ampli?ed insert encodes a portion of an amino acid sequence encoding a tyrosine ammonia lyase enZyme.
In a preferred embodiment the invention provides a method for the production of PHCA comprising: ST.25 (1998) and the sequence listing requirements of the EPO and PCT (Rules 5.2 and 49.5(a-bis), and Section 208 and Annex C of the Administrative Instructions). The sym bols and format used for nucleotide and amino acid sequence data comply With the rules set forth in 37 CFR §1.822. SEQ ID NO:1 is the N-terminal amino acid sequence of the TAL enZyme from T cutaneum. SEQ ID NO:2 is an internal amino acid sequence of the TAL enZyme from T cutaneum. The folloWing abbreviations and de?nitions Will be used for the interpretation of the speci?cation and the claims.
SEQ ID
"Phenylalanine ammonia-lyase" is abbreviated PAL. "Tyrosine ammonia-lyase" is abbreviated TAL.
"Para-hydroxycinnamic acid" is abbreviated PHCA. "Cinnamate 4-hydroxylase" is abbreviated C4H.
As used herein the terms "cinnamic acid" and "cin namate" are used interchangeably and are abbreviated CA.
The term "TAL activity" refers to the ability of a protein to catalyZe the direct conversion of tyrosine to PHCA.
The term "PAL activity" refers to the ability of a protein to catalyZe the conversion of phenylalanine to cinnamic acid.
"pal" represents a gene that encodes an enZyme With PAL activity.
"tal" represents a gene that encodes an enZyme With TAL activity.
The term "P-450/P-450 reductase system" refers to a protein system responsible for the catalytic conversion of cinnamic acid to PHCA. The P-450/P-450 reductase system is one of several enZymes or enZyme systems knoWn in the art that performs a cinnamate 4-hydroxylase function. As used herein the term "cinnamate 4-hydroxylase" Will refer to the general enZymatic activity that results in the conversion of cinnamic acid to PHCA, Whereas the term "P-450/P-450 US 6,951,751 B2 5 reductase system" Will refer to a speci?c binary protein system that has cinnamate 4-hydroxylase activity.
The term "PAL/TAL activity" or "PAL/TAL enZyme" refers to a protein Which contains both PAL and TAL activity. Such a protein has at least some speci?city for both tyrosine and phenylalanine as an enZymatic substrate. The term "catalytic ef?ciency" Will be de?ned as the kCm/KM of an enZyme. "Catalytic ef?ciency" Will be used to quantify the speci?city of an enZyme for a substrate.
The term "kcm" is often called the "turnover number". The term "kcm" is de?ned as the maximum number of substrate molecules converted to products per active site per unit time, or the number of times the enZyme turns over per unit time.
kCm=Vmax/[E], Where
is the enZyme concentration (Ferst In Enzyme Structure and Mechanism, 2"" ed.; W.H. Free man: NeW York, 1985; pp 98-120).
The term "aromatic amino acid biosynthesis" means the biological processes and enZymatic pathWays internal to a cell needed for the production of an aromatic amino acid.
The term "fermentable carbon substrate" refers to a carbon source capable of being metaboliZed by host organ isms of the present invention and particularly carbon sources selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, one-carbon substrates and/or mixtures thereof.
As used herein, an "isolated nucleic acid fragment" is a polymer of RNA or DNA that is single-or double-stranded, degree of complementation, variables Well knoWn in the art. The greater the degree of similarity or homology betWeen tWo nucleotide sequences, the greater the value of Tm for hybrids of nucleic acids having those sequences. The rela tive stability (corresponding to higher Tm) of nucleic acid hybridiZations decreases in the folloWing order: RNA: RNA, DNAzRNA, DNA:DNA. For hybrids of greater than 100 nucleotides in length, equations for calculating Tm have been derived (see Sambrook et al., supra, ). For hybridiZations With shorter nucleic acids, i.e., oligonucleotides, the position of mismatches becomes more important, and the length of the oligonucleotide determines its speci?city (see Sambrook et al., supra, . In one embodiment the length for a hybridiZable nucleic acid is at least about 10 nucleotides. Preferably a minimum length for a hybridiZable nucleic acid is at least about 15 nucleotides; more preferably at least about 20 nucleotides; and most preferably the length is at least 30 nucleotides. Furthermore, the skilled artisan Will recogniZe that the temperature and Wash solution salt concentration may be adjusted as neces sary according to factors such as length of the probe.
The term "percent identity", as knoWn in the art, is a relationship betWeen tWo or more polypeptide sequences or tWo or more polynucleotide sequences, as determined by comparing the sequences. In the art, "identity" also means the degree of sequence relatedness betWeen polypeptide or polynucleotide sequences, as the case may be, as determined by the match betWeen strings of such sequences. "Identity" and "similarity" can be readily calculated by knoWn methods, including but not limited to those described in:
Computational MolecularBiology (Lesk, A. M., ed.) Oxford University Press, NY (1988); Biocomputing: Informatics and Genome Projects (Smith, D. W., ed.) Academic Press, NY (1993); Computer Analysis of Sequence Data, Part I (Griffin, A. M., and Griffin, H. G., eds.) Humana Press, NJ (1994); Sequence Analysis in Molecular Biology (von Heinje, G., ed.) Academic Press (1987); and Sequence Analysis Primer (Gribskov, M. and Devereux, J ., eds.) Stockton Press, NY (1991) . Preferred methods to determine identity are designed to give the best match betWeen the sequences tested. Methods to determine identity and simi larity are codi?ed in publicly available computer programs.
Sequence alignments and percent identity calculations may be performed using the Megalign program of the LASER GENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences may be performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) With the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairWise alignments using the Clustal method are KTUPLE 1, GAP PENALTY= 3, WINDOW=5 and DIAGONALS SAVED=5.
A "substantial portion" of an amino acid or nucleotide sequence is that portion comprising enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to putatively identify that polypeptide or gene, either by manual evaluation of the sequence by one skilled in the art, or by computer-automated sequence comparison and identi?cation using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. ; see also WWW.ncbi.nlm.nih.gov/ BLAST/). In general, a sequence of ten or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a knoWn protein or gene.
Moreover, With respect to nucleotide sequences, gene spe ci?c oligonucleotide probes comprising 20-30 contiguous US 6,951,751 B2 7 nucleotides may be used in sequence-dependent methods of gene identi?cation (e.g., Southern hybridization) and isola tion (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12-15 bases may be used as ampli?cation primers in PCR in order to obtain a particular nucleic acid fragment com prising the primers. Accordingly, a "substantial portion" of a nucleotide sequence comprises enough of the sequence to speci?cally identify and/or isolate a nucleic acid fragment comprising the sequence. The instant speci?cation teaches partial or complete amino acid and nucleotide sequences encoding one or more particular microbial proteins. The skilled artisan, having the bene?t of the sequences as reported herein, may noW use all or a substantial portion of the disclosed sequences for purposes knoWn to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as Well as substantial portions of those sequences as de?ned above.
The invention encompasses more than the speci?c exem plary sequences because it is Well knoWn in the art that alterations in a gene Which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded protein are common. For the purposes of the present invention substi tutions are de?ned as exchanges Within one of the folloWing ?ve groups:
1. Small aliphatic, nonpolar or slightly polar residues:
Ala, Ser, Thr (Pro, Gly); 2. Polar, negatively charged residues and their amides:
Asp, Asn, Glu, Gln; 3. Polar, positively charged residues: His, Arg, Lys; 4. Large aliphatic, nonpolar residues: Met, Leu, Ile, Val (Cys); and 5. Large aromatic residues: Phe, Tyr, Trp.
Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue (such as glycine) or a more hydro phobic residue (such as valine, leucine, or isoleucine).
Similarly, changes Which result in substitution of one nega tively charged residue for another (such as aspartic acid for glutamic acid) or one positively charged residue for another (such as lysine for arginine) can also be expected to produce a functionally equivalent product. In many cases, nucleotide changes Which result in alteration of the N-terminal and C-terminal portions of the protein molecule Would also not be expected to alter the activity of the protein.
The term "complementary" is used to describe the rela tionship betWeen nucleotide bases that are capable to hybrid izing to one another. For example, With respect to DNA, adenosine is complementary to thymine and cytosine is complementary to guanine. Accordingly, the instant inven tion also includes isolated nucleic acid fragments that are complementary to the complete sequences as reported in the accompanying Sequence Listing as Well as those substan tially similar nucleic acid sequences.
Suitable nucleic acid fragments (isolated polynucleotides of the present invention) encode polypeptides that are at least about 70% identical, preferably at least about 80% identical to the amino acid sequence reported herein. Pre ferred nucleic acid fragments encode amino acid sequences that are about 85% identical to the amino acid sequence reported herein. More preferred nucleic acid fragments encode amino acid sequences that are at least about 90% identical to the amino acid sequence reported herein. Most preferred are nucleic acid fragments that encode amino acid sequences that are at least about 95% identical to the amino acid sequence reported herein. Suitable nucleic acid frag ments not only have the above homologies but typically encode a polypeptide having at least 50 amino acids, pref erably at least 100 amino acids, more preferably at least 150 amino acids, still more preferably at least 200 amino acids, and most preferably at least 250 amino acids.
"Codon degeneracy" refers to the nature in the genetic code permitting variation of the nucleotide sequence Without effecting the amino acid sequence of an encoded polypep tide. Accordingly, the instant invention relates to any nucleic acid fragment that encodes all or a substantial portion of the amino acid sequence encoding the instant microbial polypeptide as set forth in SEQ ID NO:25. The skilled artisan is Well aWare of the "codon-bias" exhibited by a speci?c host cell in usage of nucleotide codons to specify a given amino acid. Therefore, When synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.
"Synthetic genes" can be assembled from oligonucleotide building blocks that are chemically synthesized using pro cedures knoWn to those skilled in the art. These building blocks are ligated and annealed to form gene segments Which are then enzymatically assembled to construct the entire gene. "Chemically synthesized", as related to a sequence of DNA, means that the component nucleotides Were assembled in vitro. Manual chemical synthesis of DNA may be accomplished using Well-established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the genes can be tailored for optimal gene expression based on optimization of nucleotide sequence to re?ect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased toWards those codons favored by the host. Determi nation of preferred codons can be based on a survey of genes derived from the host cell Where sequence information is available.
"Gene" refers to a nucleic acid fragment that expresses a speci?c protein, including regulatory sequences preceding (5' non-coding sequences) and folloWing (3' non-coding sequences) the coding sequence. "Native gene" refers to a gene as found in nature With its oWn regulatory sequences. "Chimeric gene" refers to any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature.
"Endogenous gene" refers to a native gene in its natural location in the genome of an organism. A "foreign" gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A "transgene" is a gene that has been introduced into the genome by a trans formation procedure. "Coding sequence" refers to a DNA sequence that codes for a speci?c amino acid sequence. "Suitable regulatory sequences" refer to nucleotide sequences located upstream (5' non-coding sequences), Within, or doWnstream (3' non coding sequences) of a coding sequence, and Which in?u ence the transcription, RNA processing or stability, or trans lation of the associated coding sequence. Regulatory sequences may include promoters, translation leader US 6,951,751 B2 sequences, introns, polyadenylation recognition sequences, RNA processing site, effector binding site and stem-loop structure.
"Promoter" refers to a DNA sequence capable of control ling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3' to a promoter sequence. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental or physiological conditions. Promoters Which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". It is further recog niZed that since in most cases the exact boundaries of regulatory sequences have not been completely de?ned, DNA fragments of different lengths may have identical promoter activity.
The "3' non-coding sequences" refer to DNA sequences located doWnstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characteriZed by affecting the addition of polyade nylic acid tracts to the 3' end of the mRNA precursor.
"RNA transcript" refers to the product resulting from RNA polymerase-catalyZed transcription of a DNA sequence. When the RNA transcript is a perfect comple mentary copy of the DNA sequence, it is referred to as the primary transcript or it may be an RNA sequence derived from post-transcriptional processing of the primary tran script and is referred to as the mature RNA. "Messenger RNA (mRNA)" refers to the RNA that is Without introns and that can be translated into protein by the cell. "cDNA" refers to a double-stranded DNA that is complementary to and derived from mRNA. "Sense" RNA refers to RNA transcript that includes the mRNA and so can be translated into protein by the cell. "Antisense RNA" refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (US. Pat. No. 5,107,065; WO 9928508). The complementarity of an antisense RNA may be With any part of the speci?c gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, or the coding sequence. "Functional RNA" refers to antisense RNA, riboZyme RNA, or other RNA that is not translated yet has an effect on cellular processes.
The term "operably linked" refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked With a coding sequence When it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the tran scriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.
The term "expression", as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. Expression may be "induced" by pro viding a speci?c inducing agent to a cell that results in hightened expression of a gene. In the context of the present invention expression of the instant TAL genes are induced in by the presence of tyrosine. "Overexpression" refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms.
"Co-suppression" refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (US. Pat. No. 5,231,020).
"Transformation" refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" or "recombinant" or "transformed" organisms. The terms "plasmid", "vector" and "cassette" refer to an extra chromosomal element often carrying genes Which are not part of the central metabolism of the cell, and usually in the form of circular double-stranded DNA fragments. Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear or circular, of a single-or double-stranded DNA or RNA, derived from any source, in Which a number of nucleotide sequences have been joined or recombined into a unique construction Which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along With appropriate 3' untranslated sequence into a cell. "Transformation cassette" refers to a speci?c vector containing a foreign gene and having elements in addition to the foreign gene that facilitate transformation of a particular host cell. "Expression cassette" refers to a speci?c vector containing a foreign gene and having elements in addition to the foreign gene that alloW for enhanced expression of that gene in a foreign host.
The term "sequence analysis softWare" refers to any computer algorithm or softWare program that is useful for the analysis of nucleotide or amino acid sequences.
"Sequence analysis softWare" may be commercially avail able or independently developed. Typical sequence analysis Nucleic acid hybridization is adaptable to a variety of assay formats. One of the most suitable is the sandWich assay format. The sandWich assay is particularly adaptable to hybridiZation under non-denaturing conditions. Aprimary component of a sandWich-type assay is a solid support. The solid support has adsorbed to it or covalently coupled to it immobiliZed nucleic acid probe that is unlabeled and complementary to one portion of the sequence.
Recombinant Expression-Microbial
The gene and gene product of the instant sequence may be produced in heterologous host cells, particularly in the cells of microbial hosts.
Microbial expression systems and expression vectors con taining regulatory sequences that direct high level expres sion of foreign proteins are Well knoWn to those skilled in the art. Any of these could be used to construct chimeric genes for production of the gene product of the instant sequence. These chimeric genes could then be introduced into appropriate microorganisms via transformation to pro vide high level expression of the enZyme. Accordingly, it is expected for example that introduction Once a key genetic pathWay has been identi?ed and sequenced, speci?c genes may be upregulated to increase the output of the pathWay. Alternatively, it may be necessary to reduce or eliminate the expression of certain genes in the target pathWay or in competing pathWays that may serve as competing sinks for energy or carbon. Methods of doWn-regulating genes for this purpose have been explored. Where sequence of the gene to be disrupted is knoWn, one of the most effective methods for gene doWn regulation is targeted gene disruption Where foreign DNA is inserted into a structural gene so as to disrupt transcription. This can be effected by the creation of genetic cassettes comprising the DNA to be inserted (often a genetic . Cell. Biol. 5:270-277(1996) ).
Mol
Antisense technology is another method of doWn regu lating genes Where the sequence of the target gene is knoWn. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the anti-sense strand of RNA Will be transcribed. This construct is then introduced into the host cell and the antisense strand of RNA is produced. Antisense RNA inhib its gene expression by preventing the accumulation of mRNA Which encodes the protein of interest. The person skilled in the art Will knoW that special considerations are associated With the use of antisense technologies in order to reduce expression of particular genes. For example, the proper level of expression of antisense genes may require the use of different chimeric genes utiliZing different regu latory elements knoWn to the skilled artisan.
Although targeted gene disruption and antisense technol ogy offer effective means of doWn regulating genes Where the sequence is knoWn, other less speci?c methodologies have been developed that are not sequence based. For example, cells may be exposed to UV radiation and then screened for the desired phenotype. Mutagenesis With chemical agents is also effective for generating mutants and commonly used substances include chemicals that affect nonreplicating DNA such as HNO2 and NHZOH, as Well as 
Brock in Biotechnology: A Textbook of Industrial
Microbiology, Second Edition (1989) Sinauer Associates, Inc., Sunderland, Mass., or Deshpande, Mukund V., Appl. Biochem. Biotechnol, 36: 227 (1992) .
Another non-speci?c method of gene disruption is the use of transposable elements or transposons. Transposons are genetic elements that insert randomly in DNA but can be later retrieved on the basis of sequence to determine Where the insertion has occurred. Both in vivo and in vitro trans position methods are knoWn. Both methods involve the use of a transposable element in combination With a transposase enZyme. When the transposable element or transposon is contacted With a nucleic acid fragment in the presence of the transposase, the transposable element Will randomly insert into the nucleic acid fragment. The technique is useful for random mutagenesis and for gene isolation, since the dis Within the context of the present invention, it may be useful to modulate the expression of the PHCA producing enZyme pathWay by any one of the methods described above. For example, it Would be advantageous to maximiZe the production of tyrosine from glucose by doWn-regulating competing pathWays, such as the production of phenylala nine.
Industrial Production
Where commercial production of PHCA is desired, a variety of culture methodologies may be applied. For example, large-scale production of a speci?c gene product overexpressed from a recombinant microbial host may be produced by both batch or continuous culture methodolo g1es.
A classical batch culturing method is a closed system Where the composition of the media is set at the beginning of the culture and not subject to arti?cial alterations during the culturing process. Thus, at the beginning of the culturing process the media is inoculated With the desired organism or organisms and groWth or metabolic activity is permitted to occur adding nothing to the system. Typically, hoWever, a "batch" culture is batch With respect to the addition of carbon source and attempts are often made at controlling factors such as pH and oxygen concentration. In batch systems the metabolite and biomass compositions of the system change constantly up to the time the culture is terminated. Within batch cultures cells moderate through a static lag phase to a high groWth log phase and ?nally to a stationary phase Where groWth rate is diminished or halted.
If untreated, cells in the stationary phase Will eventually die.
Cells in log phase are often responsible for the bulk of production of end product or intermediate in some systems.
Stationary or post-exponential phase production can be obtained in other systems.
Avariation on the standard batch system is the Fed-Batch system. Fed-Batch culture processes are also suitable in the US 6,951,751 B2 17 present invention and comprise a typical batch system With the exception that the substrate is added in increments as the culture progresses. Fed-Batch systems are useful When catabolite repression is apt to inhibit the metabolism of the cells and Where it is desirable to have limited amounts of substrate in the media. Measurement of the actual substrate concentration in Fed-Batch systems is dif?cult and is there fore estimated on the basis of the changes of measurable factors such as pH, dissolved oxygen and the partial pressure Continuous or semi-continuous culture alloWs for the modulation of one factor or any number of factors that affect cell groWth or end product concentration. For example, one method Will maintain a limiting nutrient such as the carbon source or nitrogen level at a ?xed rate and alloW all other parameters to moderate. In other systems, a number of factors affecting groWth can be altered continuously While the cell concentration, measured by media turbidity, is kept constant. Continuous systems strive to maintain steady state groWth conditions and thus the cell loss due to media being draWn off must be balanced against the cell groWth rate in the culture. Methods of modulating nutrients and groWth factors for continuous culture processes as Well as tech niques for maximiZing the rate of product formation are Well knoWn in the art of industrial microbiology and a variety of methods are detailed by Brock, supra.
Fermentation media in the present invention must contain suitable carbon substrates. Suitable substrates may include but are not limited to monosaccharides such as glucose and fructose, oligosaccharides such as lactose or sucrose, polysaccharides such as starch or cellulose or mixtures thereof, and unpuri?ed mixtures from reneWable feedstocks such as cheese Whey permeate, cornsteep liquor, sugar beet molasses, and barley malt. Additionally the carbon substrate may also be one-carbon substrates such as carbon dioxide, methane or methanol for Which metabolic conversion into key biochemical intermediates has been demonstrated. In addition to one and tWo carbon substrates, methylotrophic organisms are also knoWn to utiliZe a number of other carbon containing compounds such as methylamine, glu cosamine and a variety of amino acids for metabolic activity. Arch. Microbiol. 153:485-489 (1990) ). Hence it is contemplated that the source of carbon utiliZed in the present invention may encompass a Wide variety of carbon contain ing substrates and Will only be limited by the choice of organism.
Recombinant Expression-Plants
Alternatively, the present invention provides for the pro duction of PHCA in plant cells containing the TAL gene. The nucleic acid fragment of the instant invention may be used to create transgenic plants having the ability to express the microbial gene for the production of PHCA. Preferred plant hosts Will be any variety that Will support a high production level of PHCA or PHCA-glucoside conjugate. (1989)), and thus multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accom plished by Southern analysis of DNA blots (Southern, J. Mol. Biol. 98, 503, (1975) ), Northern analysis of mRNA expression (KrocZek, J. Chromatogr Biomea'. Appl, 618 (1-2) 133-145 (1993) ), Western analysis of protein expression, or phenotypic analysis.
For some applications it Will be useful to direct the instant protein to different cellular compartments. It is thus envi sioned that the chimeric gene described above may be further supplemented by altering the coding sequences to encode enZymes With appropriate intracellular targeting sequences such as transit sequences (Keegstra, K., Cell 56:247-253 (1989) ), signal sequences or sequences encod ing endoplasmic reticulum localiZation (Chrispeels, J. J., Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53 (1991) ), or nuclear localiZation signals (Raikhel, N. Plant Phys. 100:1627 -1632 (1992 ) added and/or With targeting sequences that are already present removed. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of utility may be discovered in the future that are useful in the invention.
Protein Engineering
It is contemplated that the present nucleotides may be used to produce gene products having enhanced or altered activity. Various methods are knoWn for mutating a native gene sequence to produce a gene product With altered or enhanced activity including but not limited to error prone PCR (Melnikov et al., Nucleic Acids Research 27(4) : 1056-1062 (1999) ); site directed mutagenesis (Coombs et al., Proteins (1998) , 259-311, 1 plate, Editor(s): Angeletti, Ruth Hogue, Publisher: Academic, San Diego, Calif.), and "gene shuf?ing" (US. Pat. No. 5, 605, 793; US. Pat. No. 5, 811, 238; US. Pat. No. 5, 830, 721; and US. Pat. No. 5,837,458, incorporated herein by reference).
The method of gene shuf?ing is particularly attractive due to its facile implementation, and high rate of mutagenesis and ease of screening. The process of gene shuf?ing involves the restriction endonuclease cleavage of a gene of interest into fragments of speci?c siZe in the presence of additional populations of DNA regions of both similarity to or difference to the gene of interest. This pool of fragments Will then be denatured and reannealed to create a mutated gene. The mutated gene is then screened for altered activity.
The instant microbial sequence of the present invention may be mutated and screened for altered or enhanced activity by this method. The sequences should be double stranded and can be of various lengths ranging from 50 bp to 10 kb. The sequences may be randomly digested into fragments ranging from about 10 bp to 1000 bp, using (2002)).
After removal of the intron, the TAL gene Was cloned into US 6,951,751 B2 21 the vector pYES2.0 under the control of the yeast GAL1 promotor and successfully expressed in the yeast Saccha romyces cerevisiae. The TAL gene Was also expressed in the bacterium Escherichia coli.
EXAMPLES
The present invention is further de?ned in the following Examples. It should be understood that these Examples, While indicating preferred embodiments of the invention, are given by Way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and Without departing from the spirit and scope thereof, can make various changes and modi?cations of the invention to adapt it to various uses and conditions.
General Methods
Standard recombinant DNA and molecular cloning tech niques used in the Examples are Well knoWn in the art and are described by Sambrook, J ., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, (1989) The meaning of abbreviations is as folloWs: "s" means second(s), "min" means minute(s), "h" means hour(s), "psi" means pounds per square inch, "nm" means nanometers, "d" means day(s), "ML" means microliter(s), "mL" means milliliter(s), "L" means liter(s), "mm" means millimeter(s), "nm" means nanometers, "mM" means millimolar, "M" means molar, "mmol" means millimole(s), "umole" means micromole(s)", "g" means gram(s), "pg" means microgram(s) and "ng" means nanogram(s), "U" means units, "mU" means milliunits and "U mg_1" means units per mg, "OD" means optical density, "kDa" means kilodaltons, g means the gravitation constant.
Example 1

Screening of Various Microbial Strains Containing PAL and TAL Activity
The purpose of this Example Was to screen a variety of microbial strains for PAL/TAL activity in order to identify a strain With an enZyme that had a higher TAL than PAL activity.
Cell 
PAL and TAL Assays
The reaction Was initiated by the addition of enZyme to 50 mM Tris-HCl (pH 8.5) containing 1.0 mM L-phenylalanine or L-tyrosine and the reaction Was folloWed spectrophoto metrically by monitoring the absorbance of the product. For PAL activity, cinnamate formation Was monitored at 290 nm using a molar extinction coef?cient of 9000 cm-1. One unit of activity deaminates 1.0 umol of phenylalanine to cin namate in one min. For TAL activity, PHCA formation Was monitored at 315 nm (extinction coefficient of 10,000 cm-1). One unit of activity deaminates 1.0 umol of tyrosine to PHCA in one min.
EnZymatic Kinetic Assays
The apparent Vmax and KM values Were determined using the cell-free extracts from cells groWn in Dagley's medium in the presence of 2.0 mM tyrosine.
Results
The speci?c activity of PAL, TAL and the PAL/TAL ratio in cell-free extracts from various microbial strains are shoWn in LoW pl standards and puri?ed PAL/TAL enZyme Were used as standards for the pl 4-6.5 IEF gel.
Protein Assay
Protein concentrations Were measured as described in Example 1.
Results
As shoWn in Table 3 , a signi?cant increase in speci?c activity Was obtained folloWing puri?cation of TAL using the chromatographic techniques described above. The larg est increase Was obtained using HIC and GF, Which both gave about a 14-fold increase in speci?c activity. Since the combined molecular Weight of the 62 kDa and the 14 kDa peptides, and the 56 kDa and the 23.5 kDa peptides roughly equals the molecular Weight of the main 77.5 kDa peptide, it is likely that the 62 kDa and the 56 kDa peptides Were also degradation products. The N-terminal sequence of the 62 kDa peptide shoWed signi?cant similarity to other PAL enZymes in the database. This sequence Was designated as SEQ ID NO:2, and referred to as the internal sequence because this peptide is likely the degradation product of the 77.5 kDa peptide Without the 14 kDa N-terminal portion. (2000)) Was also used for ampli?cation With both genomic and the cDNA template. In this method, the annealing temperature Was linearly decreased from 94° C. to 55° C. over 10 minutes in each of the 30 cycles of PCR. All the other conditions Were the same as described for Touch DoWn PCR.
The folloWing primer combinations SEQ ID NOs:4 and 7, 5 and 7, and 5 and 8 generated a product With the eXpected siZe With cDNA as a template. Primer combinations SEQ ID NOs:5 and 7, and 5 and 8 also generated a product With the eXpected siZe With genomic DNA as template. These PCR products Were used as templates for a second round of ampli?cation Where the annealing temperature Was ?Xed at 55° C. for all 30 cycles. All of the second round products Were cloned into pCR2.1 as described above and 7 positive clones Were subjected to sequence analysis.
Aconsensus sequence of 1095 bp Was compiled from the positive clones obtained using the Touch DoWn and Ramped Annealing PCR methods described above. Analysis of the consensus sequence, given as SEQ ID NO:9, shoWed that it Was the reverse complement of the coding sequence. SEQ ID NO:9 Was analyZed for similarity to all publicly available DNA sequences by conducting a BLAST ( Based on the consensus sequence, SEQ ID NO:9, a set of primers Was designed for 5' and 3' RACE ampli?cation (Ohara, et al. PNAS USA 86:5673 (1989) ). These primers are listed in Table 5 . 3These are commercial primers .
5' RACE Cloning of the TAL cDNA
The Poly A(+) RNA of T cutaneum Was used for 5'-RACE cloning of tal. A 5'-end RACE kit from Life Technologies Was used, folloWing the manufacturer's pro tocol. The 5'GSP primers listed in Table 5 (SEQ ID NOs:10-14) Were used for ?rst strand cDNA synthesis. After puri?cation, a homopolymer tail (poly dC) Was added to the end of the cDNA using terminal deoXynucleotide transferase. The tailed cDNA Was then ampli?ed by PCR using Qiagen HotStarTaq master miX. The 5' end primer used Was AAP (SEQ ID NO:21), and the 3' end primers Were 5'GSP1a, 1b, 2, 3, and 4 (SEQ ID NOs:10-14). The PCR conditions used Were: 15 min at 94° C., folloWed by 30 cycles of 30 s at 94° C., 3 min from 80° C. to 55° C. linearly, 1 min at 55° C. and 2 min at 72° C. The PCR products Were used as templates for a second round of ampli?cation as shoWn in Table 6. US 6,951,751 B2 31 The results of the BLAST comparison are given in Table  7 , Which displays data based on the BLASTXnr algorithm With values reported in Expect values. The Expect value estimates the statistical signi?cance of the match, specifying the number of matches, With a given score, that are expected in a search of a database of this siZe absolutely by chance. The results shoW that the nucleotide sequence obtained for tal has a high degree of homology to knoWn PAL genes from a variety of organisms. A comparison of the TAL protein sequence (SEQ ID NO:25) With the protein sequence of the TAL from Rhodobacter capsulatus (Kyndt et al., FEBS Letters 512:240-244 (2002)) gave a 28% identity.
